Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
Abstract Background Achondroplasia (ACH), the most common form of short‐limbed skeletal dysplasia, is caused by gain‐of‐function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. More than 97% of patients result from a heterozygous p.G380R mutation in the FGFR3 gene. We present here...
Main Authors: | Tadashi Nagata, Masaki Matsushita, Kenichi Mishima, Yasunari Kamiya, Kohji Kato, Miho Toyama, Tomoo Ogi, Naoki Ishiguro, Hiroshi Kitoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1148 |
Similar Items
-
Review of published 467 achondroplasia patients: clinical and mutational spectrum
by: XinZhong Zhang, et al.
Published: (2024-01-01) -
Natural history of 39 patients with Achondroplasia
by: Jose Ricardo Magliocco Ceroni, et al.
Published: (2018-07-01) -
Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family
by: Muhammad Ajmal, et al.
Published: (2017-07-01) -
Obesity in achondroplasia patients: from evidence to medical monitoring
by: Celine Saint-Laurent, et al.
Published: (2019-11-01) -
Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia
by: Amsal Qureshi, et al.
Published: (2022-12-01)